| Health / Medical Topics |
Akt Inhibitor GDC-0068
An orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. Akt inhibitor GDC-0068 binds to and inhibits the activity of Akt in a non-ATP-competitive manner, which may result in the inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Activation of the PI3K/Akt signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K/Akt signaling may contribute to tumor resistance to a variety of antineoplastic agents. (NCI Thesaurus)
YOU MAY ALSO LIKE
A novel pyrrolopyrimidine derivative, and an orally available inhibitor of the serine/threonine protein kinase AKT (protein kinase B) with potential antineoplastic…
An orally bioavailable inhibitor of the serine/threonine protein kinase AKT (protein kinase B) with potential antineoplastic activity. AKT inhibitor ARQ 092 binds…
A molecular genetic abnormality indicating the presence of mutations in the AKT family of genes. This family includes the AKT1, AKT2,…
An orally bioavailable inhibitor of the serine/threonine protein kinase AKT (protein kinase B) isoforms 1 and 2 (AKT1/2) with potential antineoplastic…
A group of enzymes involved in several processes related to cell growth and survival. Akt enzymes help to transfer signals inside…
A British Overseas Territory comprising a peninsula on the southern coast of Cyprus.
